Maria Isabel Koerber
Latest contributions
Innovation in action: achieving optimal outcomes in mitral regurgitation
20 May 2026 – From EuroPCR 2026
A growing mitral valve portfolio is reshaping how mitral regurgitation is treated, offering tailored solutions across a broader range of patient anatomies and clinical scenarios.
This EuroPCR 2026 session focuses on innovations in transcatheter mitral therapies, highlighting how mitral transcatheter edge-to-edge repair (TEER) with the PASCAL Precision...
Secondary mitral regurgitation: not all patients are the same
20 May 2026 – From EuroPCR 2026
Examining secondary mitral regurgitation, this session differentiates patient phenotypes and discusses the application of updated guideline recommendations. It offers practical guidance on selecting the appropriate device tailored to individual patient characteristics, supported by detailed case studies.
Repair or replace the tricuspid valve: how to decide?
19 May 2026 – From EuroPCR 2026
This session focuses on decision-making in tricuspid valve interventions, balancing the choice between repair and replacement. It covers clinical and anatomical criteria guiding treatment selection, pacing lead management from an electrophysiological and surgical perspective, and the application of multimodality imaging—including TTE, TOE, and CT—to inform real-world...
Challenging tricuspid TEER cases
22 May 2025 – From EuroPCR 2025
Explore challenging tricuspid transcatheter edge-to-edge repair (TEER) cases highlighting combined LAA occlusion and mitral valve repair, anatomical complexities, and strategies to complete surgical interventions percutaneously. Discuss the balance between procedural perfection and clinical practicality in complex valve anatomies.
How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?
21 May 2025 – From EuroPCR 2025
Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.
From innovation to integration: the evolution of 4D intracardiac echocardiography in structural heart interventions
21 May 2025 – From EuroPCR 2025
Learn how 4D intracardiac echocardiography (ICE) is reshaping structural heart procedures. This EuroPCR 2025 session takes you through the latest in imaging technology—highlighting the benefits of 4D ICE and AI integration in improving the safety, precision, and efficiency of mitral and tricuspid interventions. From valve repair...
How to deal with secondary mitral regurgitation in 2025?
20 May 2025 – From EuroPCR 2025
Delve into the evolving management of secondary mitral regurgitation, and the critical role of the Heart Team. This session replay presents the latest clinical trials, treatment guidelines, and a case-based discussion covering medical and interventional strategies, heart failure optimization, frailty assessment, and advanced imaging techniques.
Tailoring transcatheter mitral therapies: a new era
20 May 2025 – From EuroPCR 2025
This session focuses on the evolving landscape of transcatheter mitral valve therapies. Learn about strategic programme development, patient phenotyping to guide device selection and repair versus replacement decisions, and the latest innovations and approvals in transcatheter mitral valve replacement.
